Compounds > sk&f-38393
Page last updated: 2024-10-21

sk&f-38393 and Developmental Psychomotor Disorders

sk&f-38393 has been researched along with Developmental Psychomotor Disorders in 1 studies

2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine: A selective D1 dopamine receptor agonist used primarily as a research tool.
1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol : A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1 and two hydroxy substituents at positions 7 and 8.
SKF 38393 : A racemate comprising equimolar amounts of (R)- and (S)-SKF 38393

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Managò, F1
Mereu, M1
Mastwal, S1
Mastrogiacomo, R1
Scheggia, D1
Emanuele, M1
De Luca, MA1
Weinberger, DR1
Wang, KH1
Papaleo, F1

Other Studies

1 other study available for sk&f-38393 and Developmental Psychomotor Disorders

ArticleYear
Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia.
    Cell reports, 2016, 08-23, Volume: 16, Issue:8

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Cognitive Dysfunct

2016